Frank Biden Opens Up About Psychedelics to Brother Joe Biden Amidst Growing Push for Legalization

In a surprising revelation, Frank Biden, brother of President Joe Biden, has disclosed that he has discussed the potential benefits of psychedelics for medical treatment with the President. As the psychedelic industry gains momentum in its push for legalization, Frank Biden’s candid remarks shed light on the Biden family’s stance on this controversial topic. Join us as we explore the intriguing conversation between the Biden brothers and the implications it holds for the future of psychedelic medicine.

Table of Contents show

Frank Biden Advocates for Psychedelics

During a recent interview on SiriusXM’s The Michael Smerconish Program, Frank Biden expressed his belief that psychedelics, such as ketamine, LSD, and ayahuasca, should be considered medicinal substances. He emphasized the problem of their current illegal status and the need for a shift in societal perception. With a deep conviction in the potential of psychedelics, Frank Biden shared his views, daring to challenge the existing norms surrounding these substances.

A Brotherly Exchange

In a remarkable exchange, Smerconish asked Frank Biden if he had ever shared his perspectives with President Joe Biden. Surprisingly, Biden confirmed that he had indeed discussed his views with his older brother, highlighting the President’s open-mindedness. While Frank Biden refrained from divulging too much, the conversation between the brothers revealed a unique dynamic and the possibility of influencing the President’s perspective on this contentious issue.

The Voice in the President’s Ear

Following the interview, Smerconish and his co-host acknowledged the significance of Frank Biden’s voice in the President’s ear. This revelation hints at the potential impact Frank Biden’s opinions may have on shaping the administration’s policies and approach to psychedelic medicine. With such proximity to power, questions arise about the extent to which familial discussions influence the President’s decision-making process.

Hunter Biden’s Involvement

Frank Biden’s endorsement of psychedelics is not an isolated occurrence within the Biden family. In his memoir Beautiful Things, Hunter Biden detailed his personal experiences with psychedelics, including ibogaine and 5-MeO-DMT therapy. Although these substances are illegal in the United States, Hunter Biden’s firsthand account sheds light on their potential therapeutic benefits. The Biden family’s exploration of psychedelics underscores the growing interest in alternative medical treatments.

Psychedelic Science 2023 Conference

Frank Biden’s vocal support for psychedelics comes on the heels of the Psychedelic Science 2023 conference held in Colorado. The event, hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), explores the therapeutic potential of psychedelics and advocates for their responsible use. The conference’s focus on changing public perception and promoting research aligns with Frank Biden’s call for increased awareness and acceptance of psychedelic medicine.

Ethical Questions and Financial Interests

Frank Biden’s involvement with companies associated with psychedelics, such as BioSig Technologies, raises ethical concerns. Reports suggest that he has spoken at health care conferences, promising to assist attendees in lobbying the federal government. While the extent of his financial interests in these ventures remains unclear, scrutiny surrounding potential conflicts of interest emerges. The evolving narrative surrounding his relationship with BioSig calls for further investigation into these matters.

Conclusion

Frank Biden’s candid conversation with President Joe Biden regarding the merits of psychedelic medicine adds a new dimension to the ongoing debate on drug legalization. As the push for psychedelics gains traction, the influence of familial discussions on policy decisions becomes an intriguing topic of discussion. Will the Biden administration signal a shift in attitudes towards psychedelics, or will the status quo prevail? Only time will tell. Share your thoughts on this dynamic exchange and join the conversation on the future of psychedelic medicine.